Eric Shiozaki, PhD
Partner at Revelation Partners
About
Eric Shiozaki joined Revelation Partners in 2024, where he identifies and leads new investment opportunities with a focus on biopharma and medical devices. He was previously a Partner at DCVC Bio, where he led early-stage biotechnology investments, and a Partner at Novo Ventures, where he built the firm's public equities strategy in therapeutics and medical devices. Earlier roles include Director at Apposite Capital and Associate at Burrill & Company; he holds a BA in Biophysics from Johns Hopkins University and a PhD in Molecular Biology from Princeton University.
Invests in
BiotechHealthtechMedical Devices
Colleagues at Revelation Partners
Chris Bayliss
Vice President at Revelation Partners
Colleen Hochberger
Manager, Marketing & Operations at Revelation Partners
Doug Fisher
Partner, MD at Revelation Partners
Doug Fisher, MD
Partner at Revelation Partners
Eric Shiozaki
Partner, PhD at Revelation Partners
Fred Lee
Partner at Revelation Partners
Garrett Brown
Senior Associate at Revelation Partners
Jonathan Au
Partner at Revelation Partners